BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33977107)

  • 21. [The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells].
    Wang Y; Zhou YT; Zhao Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):344-7. PubMed ID: 20368112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
    Giuliano M; Pellerito O; Portanova P; Calvaruso G; Santulli A; De Blasio A; Vento R; Tesoriere G
    Biochimie; 2009 Apr; 91(4):457-65. PubMed ID: 19059457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway.
    Cao WQ; Zhai XQ; Ma JW; Fu XQ; Zhao BS; Zhang P; Fu XY
    Pharm Biol; 2020 Dec; 58(1):72-79. PubMed ID: 31875760
    [No Abstract]   [Full Text] [Related]  

  • 24. The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft.
    Scuderi MR; Cantarella G; Scollo M; Lempereur L; Palumbo M; Saccani-Jotti G; Bernardini R
    Cancer Lett; 2011 Nov; 310(2):240-9. PubMed ID: 21807457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
    Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
    Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
    Qamri Z; Preet A; Nasser MW; Bass CE; Leone G; Barsky SH; Ganju RK
    Mol Cancer Ther; 2009 Nov; 8(11):3117-29. PubMed ID: 19887554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.
    Sreevalsan S; Safe S
    Mol Cancer Ther; 2013 Nov; 12(11):2483-93. PubMed ID: 24030632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K/AKT signaling pathway.
    Nan Y; Guo L; Song Y; Wang L; Yu K; Huang Q; Zhong Y
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1477-1487. PubMed ID: 28401302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner.
    Notaro A; Emanuele S; Geraci F; D'Anneo A; Lauricella M; Calvaruso G; Giuliano M
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q; Bhat M; Bowen WD; Cheng J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2.
    Zhang G; Bi H; Gao J; Lu X; Zheng Y
    Cell Biochem Funct; 2016 Jul; 34(5):351-8. PubMed ID: 27309350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.
    Notaro A; Sabella S; Pellerito O; Di Fiore R; De Blasio A; Vento R; Calvaruso G; Giuliano M
    Int J Biol Sci; 2014; 10(5):466-78. PubMed ID: 24795528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mulberry fruit (Moris fructus) extracts induce human glioma cell death in vitro through ROS-dependent mitochondrial pathway and inhibits glioma tumor growth in vivo.
    Jeong JC; Jang SW; Kim TH; Kwon CH; Kim YK
    Nutr Cancer; 2010; 62(3):402-12. PubMed ID: 20358478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caudatin Inhibits Human Glioma Cells Growth Through Triggering DNA Damage-Mediated Cell Cycle Arrest.
    Fu XY; Zhang S; Wang K; Yang MF; Fan CD; Sun BL
    Cell Mol Neurobiol; 2015 Oct; 35(7):953-9. PubMed ID: 25860846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells.
    Xu D; Wang J; Zhou Z; He Z; Zhao Q
    Mol Med Rep; 2015 Dec; 12(6):7963-70. PubMed ID: 26500101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
    Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
    Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent.
    Sreevalsan S; Joseph S; Jutooru I; Chadalapaka G; Safe SH
    Anticancer Res; 2011 Nov; 31(11):3799-807. PubMed ID: 22110202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harmine inhibits the proliferation and migration of glioblastoma cells via the FAK/AKT pathway.
    Zhu YG; Lv YX; Guo CY; Xiao ZM; Jiang QG; Kuang H; Zhang WH; Hu P
    Life Sci; 2021 Apr; 270():119112. PubMed ID: 33508300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells.
    Park JM; Xian XS; Choi MG; Park H; Cho YK; Lee IS; Kim SW; Chung IS
    J Cell Biochem; 2011 Apr; 112(4):1192-205. PubMed ID: 21312237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis.
    Leconte M; Nicco C; Ngô C; Arkwright S; Chéreau C; Guibourdenche J; Weill B; Chapron C; Dousset B; Batteux F
    Am J Pathol; 2010 Dec; 177(6):2963-70. PubMed ID: 21057002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.